Company

Ligand Pharmaceuticals Inc LGND

Tracked across 2 disclosed holders on Protégé.

1 tracked investor, latest 13F quarter ending 30 Jun 2026 · 1 member of Congress · latest filing 14 Aug 2026

Held by these investors

All of 1 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Aristeia Capital0.4%$11.8M2026-06-302026-08-14

Members of Congress who disclosed trades

Disclosed trades by members of Congress. Net is buys minus sells at range midpoints. Source: STOCK Act periodic transaction reports; latest trade date per row.
PoliticianDisclosed activityEst. netLatest trade
Gilbert Cisneros4 buys / 0 sells$32K2026-05-29

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for LGND